HBM Partners
Venture capitalZug · Pre-Seed–Late Stage · 4 people tracked
Investment thesis
HBM Partners is a Swiss healthcare-focused investor managing about USD 2.1 billion and regulated by FINMA. It engages in venture, growth and buy-out financings of private companies and investments in public companies within biopharma, medtech, diagnostics and healthcare. It invests across Europe, North America, India, China and other emerging markets, with typical investments ranging from USD 5 to 50 million. The firm advises SIX-listed HBM Healthcare Investments Ltd and several specialised funds, and supports portfolio companies across all development stages by leveraging its industry experience and global network. Its track record includes over 100 investments producing more than 60 trade sales and IPOs.
Source: firm website, verified Aug 2, 2026.
Team · 4 people
from the firm's website
Didier de Montmollin is a founding partner of DGE Attorneys at law and specializes in Swiss banking law. He serves on the Executive Committee of the Swiss Bar Association's Anti-Money Laundering Regulatory Authority and is one of four counsel appointed by the Swiss Bankers Association to investigate member banks' violations of the Swiss bank Code of Conduct on due diligence.
Ulrich Geilinger has more than 25 years of experience in the venture capital industry. He holds a PhD from ETH Zurich in Natural Sciences and Industrial Engineering. His earlier career included management roles at Innoventure, Credit Suisse, Apax, and Vontobel.
Serves as Chairman of the Board at HBM Partners.
Frequently asked questions
- What stage does HBM Partners invest at?
- HBM Partners invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is HBM Partners's typical check size?
- HBM Partners typically writes checks of $5M – $50M.
- What sectors does HBM Partners focus on?
- HBM Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is HBM Partners located?
- HBM Partners is headquartered in Zug, CH.
Similar investors
Amadeus Capital Partners is a technology investor. It held a first close of $75M on its Amadeus IV Digital Prosperity Fund, focused on late-stage venture and growth companies building online and mobile services for emerging-market middle classes.
B Capital Group is a multistage venture capital firm that invests from seed to late stage, offering value-added support to founders in partnership with management consulting firm BCG.
DCVC (Data Collective) is a deep tech venture capital firm backing entrepreneurs using computational approaches to solve large real-world problems across many industries. It operates six flagship funds plus DCVC Bio, spanning 13 funds to date.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
Kleiner Perkins is a venture capital firm that partners with entrepreneurs to build technology companies, with a history of backing companies from early stage through IPO.